Bioprocessing · Biopharma · Biotech — AI Consulting
CellCraft AI helps biopharma and biotech organizations apply artificial intelligence to bioprocessing, upstream & downstream operations, and drug development — turning biological complexity into competitive advantage.
About
Suresh is a specialist at the convergence of bioprocessing science and artificial intelligence. With deep expertise in upstream and downstream bioprocess development, cell culture engineering, and AI-driven process optimization, he founded CellCraft AI to help biopharma and biotech organizations unlock the full potential of their biological manufacturing operations.
Before launching CellCraft AI, Suresh led bioprocess and digital strategy initiatives across global pharmaceutical and contract manufacturing organizations — from early-stage cell line development through commercial-scale GMP production. He brings rare fluency in both the science of bioprocessing and the practical realities of AI deployment in regulated environments.
CellCraft AI partners with CDMOs, gene & cell therapy companies, biologics manufacturers, and biotech startups to design and implement AI solutions that improve yield, reduce variability, and accelerate time-to-clinic and time-to-market.
Hands-on expertise in upstream cell culture, fermentation, downstream purification, and GMP manufacturing — the foundation for meaningful AI application.
Deploying machine learning, digital twins, and predictive process analytics in GxP-compliant environments to improve yield, consistency, and scalability.
Guiding leadership teams on AI roadmaps, technology investments, and partnerships that align with regulatory expectations and commercial timelines.
Services
Build AI-powered process models and digital twins for upstream cell culture, fermentation, and downstream purification — enabling real-time optimization and predictive control.
Accelerate DoE, media optimization, and scale-up using machine learning to navigate the high-dimensional parameter space of bioprocess development faster and with fewer experiments.
Apply AI to Process Analytical Technology (PAT) data streams for real-time release, anomaly detection, and continuous process verification in GMP manufacturing.
Define a clear AI strategy tailored to your pipeline, data maturity, and organizational goals — from opportunity assessment through multi-year execution planning.
Navigate FDA, EMA, and ICH expectations for AI/ML in biomanufacturing. Design compliant validation frameworks, control strategies, and submission-ready documentation.
Build lasting internal AI capability through bespoke workshops, embedded advisory, and training programs designed for bioprocess scientists and manufacturing teams.
Insights
Bioprocessing AI
How leading CDMOs and biologics manufacturers are moving beyond pilot projects to deploy AI process models at commercial scale.
April 2025
Process Development
A practical assessment of ML approaches for fed-batch and perfusion culture — separating genuine productivity gains from overfitted models.
March 2025
Regulatory
Breaking down the FDA's latest guidance on AI/ML-based process control and what it means for your BLA and continuous manufacturing strategy.
February 2025
Contact
Whether you're optimizing a cell culture process, building a digital twin, or defining your organization's AI strategy, we'd love to hear from you. Most engagements begin with a complimentary discovery call.